770221000168103: Oralair Continuation Treatment 300 IR (Anthoxanthum odoratum pollen extract 60 IR + Dactylis glomerata pollen extract 60 IR + Lolium perenne pollen extract 60 IR + Phleum pratense pollen extract 60 IR + Poa pratensis pollen extract 60 IR) sublingual tablet (trade product unit of use)

• Australian concept\Australian product\...
• \trade product\trade product unit of use\Oralair Continuation Treatment 300 IR sublingual tablet
• \trade product\Oralair Continuation Treatment 300 IR\Oralair Continuation Treatment 300 IR sublingual tablet
• \medicinal product\medicinal product unit of use\trade product unit of use\Oralair Continuation Treatment 300 IR sublingual tablet
• \medicinal product\medicinal product unit of use\Dactylis glomerata pollen extract + Poa pratensis pollen extract + Lolium perenne pollen extract + Anthoxanthum odoratum pollen extract + Phleum pratense pollen extract (total 300 IR) sublingual tablet\Oralair Continuation Treatment 300 IR sublingual tablet
• \medicinal product\Lolium perenne pollen extract\Dactylis glomerata pollen extract + Lolium perenne pollen extract + Phleum pratense pollen extract\Dactylis glomerata pollen extract + Poa pratensis pollen extract + Lolium perenne pollen extract + Anthoxanthum odoratum pollen extract + Phleum pratense pollen extract\Dactylis glomerata pollen extract + Poa pratensis pollen extract + Lolium perenne pollen extract + Anthoxanthum odoratum pollen extract + Phleum pratense pollen extract (total 300 IR) sublingual tablet\Oralair Continuation Treatment 300 IR sublingual tablet
• \medicinal product\Phleum pratense pollen extract\Dactylis glomerata pollen extract + Lolium perenne pollen extract + Phleum pratense pollen extract\Dactylis glomerata pollen extract + Poa pratensis pollen extract + Lolium perenne pollen extract + Anthoxanthum odoratum pollen extract + Phleum pratense pollen extract\Dactylis glomerata pollen extract + Poa pratensis pollen extract + Lolium perenne pollen extract + Anthoxanthum odoratum pollen extract + Phleum pratense pollen extract (total 300 IR) sublingual tablet\Oralair Continuation Treatment 300 IR sublingual tablet

Status: current, Defined. Date: 31-Mar 2016. Module: Australian Medicines Terminology module

Descriptions:

Id	Description	Lang	Type	Status	Case?	Module
1561691000168117	Oralair Continuation Treatment 300 IR (Anthoxanthum odoratum pollen extract 60 IR + Dactylis glomerata pollen extract 60 IR + Lolium perenne pollen extract 60 IR + Phleum pratense pollen extract 60 IR + Poa pratensis pollen extract 60 IR) sublingual tablet (trade product unit of use)	en	Fully specified name	Active	Case sensitive	Australian Medicines Terminology module
1561701000168117	Oralair Continuation Treatment 300 IR sublingual tablet	en	Synonym	Active	Case sensitive	Australian Medicines Terminology module

Expanded Value Set

Reference Sets

Trade product unit of use reference set

Back to Start